NEUKIO - Search

Home

About Neukio

Corporate Overview

Development History

Corporate Culture

About Founder

Core Team

R&D

R&D Platform

Process Development

News

Press Releases

BD cooperation

BD cooperation

Contact us

中

En

Back

Find 27 results

Search by Column

Search by time

Within one week

Within one month

Within one year

China Biotech Industry: Six foreign-invested enterprises gain approval to engage in stem cell research activities >>
【Reprinted from Han Kun Law Offices】China Pilots Lifting Restrictions on Foreign Investment in Stem Cell, Gene Therapy, and Genetic Diagnosis Sectors in Four Free Trade Zones >>
Richard Liqun Wang: China's Cell and Gene Therapy Poised to Take the Lead >>
Neukio Biotherapeutics and Tofflon Life Sciences Successfully Deliver Customized Glass Bioreactors >>
Richard Wang: A Seventeen-Year Odyssey of an Overseas PhD Returnee in the Pursuit of Domestic Innovative Drug Development >>
Richard Wang: Perks enjoyed by companies based in the FTZ >>
Neukio Biotherapeutics Reached Strategic Collaboration with Tofflon Science and Technology Group Co. Ltd to Expedite Large-scale Production of Next Generation Allogenic Cell Therapies >>
Neukio Biotherapeutics completed Series A-1 financing, to accelerate discovery and development of next generation cell therapy products >>

1